SOP for Maintenance of QC Laboratory Instruments

In short: This illustrative SOP gives QC teams a framework for maintaining, calibrating, servicing, and documenting laboratory instruments. Set activities and intervals for each instrument’s intended use, risk, performance, manufacturer instructions, and applicable requirements; adapt and approve the procedure under the site quality system before use.

Objective

Describe a controlled approach for maintaining laboratory instruments so they remain suitable for their intended use and maintenance does not put product quality at risk. EU GMP Part I, Chapter 3, §§3.34–3.35 (2015) addresses intended-purpose maintenance and protecting product quality during repair; Chapter 6, §6.7 (2014) calls for laboratory procedures and records covering instrument calibration or qualification and equipment maintenance.

Scope

This example covers instruments and equipment used by a pharmaceutical Quality Control laboratory. Example in-house criterion (not a pharmacopoeial requirement): Maintain equipment-specific procedures where this template does not adequately address an instrument. This is a template only, not an approved site SOP; adapt it to the equipment, quality system, product, and markets involved.

Responsibilities

Example in-house criterion (not a pharmacopoeial requirement): The role allocation below is a starting point; align it with local job titles and approval responsibilities.

• Instrument user or assigned owner: use the instrument only when its status permits use, follow the approved operating procedure, and report faults or overdue activities.
• QC supervisor or designee: maintain the site inventory and schedule, review service and calibration evidence, and assess the effect of equipment issues on testing.
• Quality Unit: approve procedures and relevant records, and oversee investigations or quality decisions where instrument status may affect product quality.
• Engineering or service personnel: perform assigned work under approved procedures and provide a report of work and results. Qualification and maintenance work should be performed by suitably trained personnel following approved procedures (EU GMP Annex 15, §§1.2 and 3, 2015).

Procedure

1. Identify and qualify equipment

Before routine use, document the instrument’s identity, location, intended use, and status. Define the qualification scope through the site’s equipment lifecycle process and a justified risk assessment. Review supplier documents for suitability and complete the site checks required by the approved protocol before releasing the instrument for use. Annex 15 (2015) describes lifecycle qualification and says third-party protocols must be reviewed for suitability and compliance with internal procedures before approval.

The original template assigns qualification only to a manufacturer’s or supplier’s service engineer. The cited guidance requires suitably trained personnel and appropriate site oversight but does not establish a universal vendor-only rule.

Example in-house criterion (not a pharmacopoeial requirement): Keep an instrument inventory and history record that identify the instrument, owner, location, intended use, qualification status, service events, calibration status, and approved return-to-use decision.

2. Plan preventive maintenance

Establish written maintenance procedures and schedules where required. Set instrument-specific activities using applicable GMP requirements, intended use, manufacturer instructions, equipment condition, and documented site assessment. Repair and maintenance work should not create a hazard to product quality. For equipment used in manufacture, processing, packing, or holding, 21 CFR 211.67 (current eCFR, accessed 16 October 2026) requires written cleaning and maintenance procedures, including schedules, and associated records. EU GMP Part I, Chapter 3, §§3.34–3.35 (2015) covers intended-purpose maintenance and quality risks from repair.

3. Plan calibration and checks

For instruments, apparatus, gauges, and recording devices, establish a written calibration programme with suitable intervals, directions, schedules, accuracy and precision limits, and remedial action if limits are not met. Do not use an instrument that fails its established specifications (21 CFR 211.160(b)(4), current eCFR, accessed 16 October 2026). EU GMP Part I, Chapter 3, §3.41 (2015) calls for calibration and checks at defined intervals using appropriate methods, with adequate records.

The original template proposes an annual preventive-maintenance schedule and a yearly calibration planner. These may be used as local planning choices only after assessing each instrument; the cited requirements do not establish one annual interval for every instrument.

Example in-house criterion (not a pharmacopoeial requirement): Maintain a yearly planner that shows each instrument’s approved maintenance and calibration due dates, completion dates, and authorised changes to the plan. Use instrument-specific intervals approved through the site quality system.

4. Manage faults, repairs, and return to use

If an instrument is defective or outside its approved status, prevent its unintended use. EU GMP Part I, Chapter 3, §3.44 (2015) says defective equipment should, if possible, be removed from production and QC areas or clearly labelled as defective. Example in-house criterion (not a pharmacopoeial requirement): Notify the supervisor and Quality Unit when testing or product decisions may be affected. Document the fault, work performed, service findings, and assessment of affected results before return to use.

Example in-house criterion (not a pharmacopoeial requirement): Raise a work order for service, use an approved internal or external technician, review the service report, and record who authorised the instrument’s return to routine use. If the fault may affect reported results or product quality, open an investigation under the approved laboratory incident process. See the SOP for laboratory incidents.

5. Maintain records and training

Keep procedures and records for instrument calibration or qualification and equipment maintenance available to QC, as described in EU GMP Part I, Chapter 6, §6.7 (2014). For U.S.-regulated drug products, 21 CFR 211.67(c) requires maintenance records as specified in §§211.180 and 211.182; §211.180(a) requires batch-associated production, control, or distribution records to be retained at least one year after the respective batch’s expiry. EU GMP Part I, Chapter 4, §4.11 (January 2011) requires batch documentation to be kept for one year after expiry or at least five years after QP certification, whichever is longer. Apply any longer period required by applicable law or the marketing authorisation. For instrument records not linked to a batch, follow the applicable approved record-retention schedule.

Example in-house criterion (not a pharmacopoeial requirement): Record the equipment ID, work date, reason for work, technician, work performed, findings or results, related calibration/service report, and the authorised status after work. Train affected personnel on the approved procedure and retain training evidence under the site’s record-control process.

Abbreviations

• GMP: Good Manufacturing Practice
• QC: Quality Control
• SOP: Standard Operating Procedure
• QP: Qualified Person

Related procedures

For calibration workflows, see SOP for calibration and calibration of equipment and instruments. For equipment performance qualification context, see qualification stages for equipment and systems.

Frequently asked questions

Must a supplier’s engineer perform equipment qualification?

The reviewed EU GMP Annex 15 (2015) requires suitably trained personnel to perform qualification and says supplier protocols must be reviewed for suitability before approval. It does not establish a universal rule that only the manufacturer or supplier can perform the work. A site may set a stricter local process if justified and approved.

Should every instrument be maintained and calibrated annually?

The cited requirements do not set a universal annual interval. Use intervals established through the written programme and applicable requirements, with consideration of the instrument and its intended use. Any annual schedule in this template is an example in-house criterion, not a universal GMP interval.

How long should instrument records be retained?

When an instrument record supports batch-associated production, control, or distribution documentation, retain it at least one year after the respective batch’s expiry under 21 CFR 211.180(a), where applicable. EU GMP Part I, Chapter 4, §4.11 (January 2011) sets a five-year-after-QP-certification alternative when that is longer. Follow longer applicable requirements.

References

• European Commission. EudraLex Volume 4, EU GMP Guide, Part I, Chapter 3: Premises and Equipment, §§3.34–3.35, 3.41, 3.44 (2015; effective 1 March 2015). Official chapter.
• European Commission. EudraLex Volume 4, EU GMP Guide, Part I, Chapter 4: Documentation, §4.11 (January 2011). Official chapter.
• European Commission. EudraLex Volume 4, EU GMP Guide, Part I, Chapter 6: Quality Control, §§6.5–6.8 (2014; effective 1 October 2014). Official chapter.
• European Commission. EudraLex Volume 4, Annex 15: Qualification and Validation, §§1.2, 2.6, 3 (2015; effective 1 October 2015). Official annex.
• U.S. Electronic Code of Federal Regulations, current as of 14 October 2026: 21 CFR §§211.67, 211.160(b)(4), 211.180(a). Official eCFR text.

Revision history

This is an illustrative template, not a controlled site procedure. Add the approved document number, effective date, and change history when adapting it under a site quality system.